(Circulation. 2007;116:I-192 – I-199.)
© 2007 American Heart Association, Inc.
Surgery for Coronary Artery Disease |
From the Emory Heart Center (J.D.P., S.V.P., O.L., R.A.G.), Division of Cardiothoracic Surgery, Clinical Research Unit, Emory University School of Medicine, Atlanta, Ga; and the Department of Biostatistics (P.D.K., M.K.), Rollins School of Public Health, Emory University, Atlanta, Ga.
Correspondence to John D. Puskas, MD, MSc, Associate Chief of Cardiothoracic Surgery, Emory University, Chief of Cardiac Surgery, Emory Crawford Long Hospital, 6th Floor Medical Office Tower, 550 Peachtree St NE, Atlanta, GA 30308. E-mail john.puskas{at}emoryhealthcare.org
| Abstract |
|---|
|
|
|---|
Methods and Results— Retrospective review of risk factors and clinical outcomes for 11 413 consecutive patients having isolated CABG between January 1, 1997, and May 31, 2005, at a US academic center. Interventions were OPCAB or CABG/CPB, performed at the discretion of 14 faculty surgeons. Main outcome measures included in-hospital death, stroke, myocardial infarction or combined major adverse cardiac events (MACE=death or stroke or myocardial infarction). Odds ratios of adverse events, adjusted for 31 risk factors, were compared between women and men who had OPCAB versus CABG/CPB. Covariates included Propensity Score, Society of Thoracic Surgeons Predicted Risk, surgeon and body habitus. Female patients (n=3248) and those treated with OPCAB (n=4492) were older, had more comorbidities and higher predicted risk than male patients (n=8165) and those treated with conventional CABG/CPB (n=6921), respectively. Women treated with CABG/CPB had a risk-adjusted odds ratio of 1.60 for death (P=0.01), 1.71 for stroke (P=0.007), 2.26 for myocardial infarction (P=0.008) and 1.71 for MACE (P<0.001) compared with men who had CABG/CPB. In contrast, women treated with OPCAB had outcomes statistically similar to men who had either OPCAB or CABG/CPB. Among women, OPCAB was associated with a significant reduction in death (OR 0.39, P=0.001), stroke (OR 0.43, P=0.002) and MACE (OR 0.43, P<0.001).
Conclusions— OPCAB is associated with fewer major adverse cardiac events and benefits women disproportionately, thereby narrowing the gender disparity in clinical outcomes after CABG.
Key Words: cardiopulmonary bypass surgery coronary disease
| Introduction |
|---|
|
|
|---|
The present study was designed to assess in-hospital outcomes for women and men having CABG to determine whether OPCAB may alter the gender-based disparity in morbidity and mortality.
| Methods |
|---|
|
|
|---|
|
|
Interventions, Surgeons and Surgical Technique
Each patient underwent one surgical session consisting of OPCAB or CABG on CPB, performed at the discretion of any of 14 faculty surgeons, who varied in their adoption of off-pump surgery. OPCAB was performed with one of several commercially available cardiac positioning and coronary artery stabilizing devices, using techniques that have been previously described.15 Conventional CABG on CPB was performed with standard techniques, using roller head pumps, membrane oxygenators, cardiotomy suction, arterial filters, cold antegrade and retrograde blood cardioplegia and moderate systemic hypothermia (30°C to 34°C). Patients who were converted intraoperatively from OPCAB to CABG on CPB or from CABG on CPB to OPCAB were entered into the database and analyzed according to the operation they ultimately received.
Data Management and Statistical Analysis
All data for consecutive patients were prospectively entered into a computerized cardiac surgical database, using the data fields and definitions of the STS National Adult Cardiac Database. Rigorous checks for data quality are used both at the institutional level and before final entry into the STS national adult cardiac database. Data were managed by local database staff, and warehoused in locked, secure facilities, protected by computer passwords and firewalls.
Before analysis, 31 candidate risk factors were selected and deemed potentially important predictors of surgical group assignment (OPCAB or CABG on CPB) or clinical outcomes. Table 1 lists these risk factors. Diabetes was classified into 3 categories: none, noninsulin-dependent and insulin-dependent. Previous MI and time since MI were collapsed into one variable. A body size scale (hereafter called Body Size) from Habib et al19 was used to evaluate the body habitus of each patient, and this score was included in the final analysis to determine whether Body Size was a confounder of gender in influencing adverse outcomes. This score incorporates both body mass index (BMI) and body surface area (BSA) and divides patients into 5 classes. The classes are as follows: very small (BSA
1.70); slightly small (1.70 <BSA
1.85); moderately obese (32 <BMI <36); very obese (BMI
36); and normal (BSA >1.85 and 22 <BMI
32). The STS Database management has developed a proprietary mathematical model that allows estimation of mortality risk based on preoperative patient characteristics. This STS Predicted Risk Model is widely reported and validated in the literature.20
|
The database was populated prospectively and thoroughly; consequently, <4% of all data points were missing. Multiple imputation strategies based on maximum likelihood described by Rubin et al21 were used to impute the few missing values. Data were 100% complete for critical risk factors such as gender and surgery type (OPCAB or CABG on CPB) as well as for each postoperative end point—death, stroke and MI.
The retrospective nature and low event rates of the study recommended the use of propensity scoring methods. This approach "balances" patients with respect to the effect of their preoperative risk factors on their probability of group assignment (OPCAB versus CABG on CPB).22,23 Importantly, gender, Body Size, and STS predicted risk of mortality were not used to estimate the propensity score, but were used in the final outcomes models, because their direct influence on the outcomes was of primary interest. As such, 28 risk factors (including surgeon identity) and several binary indicators of missing data23 were used nonparsimoniously in a multivariable logistic regression (MLR) model to predict surgery type. The resulting estimated probability of being treated with OPCAB, conditional on the risk factor values, is the propensity score. The propensity score was included as a covariate of risk in the final MLR models of outcomes.22,23
To address the primary study end points, separate MLR models of outcomes were constructed that regressed the dichotomous end points (death, stroke, MI, major adverse cardiac events [MACE]) as a function of treatment (OPCAB versus CABG on CPB), gender and the interaction of treatment and gender. Additionally, Body Size, STS Predicted Risk of Mortality, surgeon identity and the propensity score were modeled as prespecified covariates of risk. Surgeon identity was modeled as a random effect because patients are "clustered" under surgeons in a random manner. The treatment of surgeon as a random effect allows for the generalization of the model inferences to other populations. These 4 models (one model per outcome) reflect a conservative approach in measuring the association between the outcomes and the risk factors because important covariates (Predicted Risk of Mortality, and Body Size) are directly adjusted and not mixed with other propensity covariates in a nonparsimonious fashion.
These final models were used to assess the association between the outcomes and the predictors and to generate adjusted odds ratios of exposure to adverse postoperative events. Five preplanned comparisons for each of the 4 MLR models were of interest: (1) female CABG on CPB versus female OPCAB, (2) male CABG on CPB versus male OPCAB, (3) female CABG on CPB versus male CPB, (4) female OPCAB versus male OPCAB, and (5) female OPCAB versus male CABG on CPB.
The data were primarily summarized using SAS Version 9.1. STATA version 9.1 was used to fit the logistic regression model (XTLOGIT function) with surgeon identity as the clustered random effect. All statistical tests were performed using a 2-tailed 0.05 level of significance. All comparisons and model terms were preplanned.
The authors had full access to the data and take responsibility for its integrity. All authors have read and agree to the manuscript as written.
| Results |
|---|
|
|
|---|
|
Unadjusted Outcomes
Women experienced significantly higher incidences of death (3.0 versus 1.6%), stroke (2.5 versus 1.4%), MI (1.2 versus 0.6%) and the combined end point of MACE (6.0 versus 3.3%) than men after coronary bypass surgery (Table 3). Patients who had OPCAB had significantly lower incidences of death (1.4 versus 2.4%), stroke (1.2 versus 2.0%) and the combined end point of MACE (2.9 versus 4.8%) than patients who had CABG on CPB. Observed (O) to expected (E) mortality ratios were highest for women who had CABG on CPB (O/E ratio 1.38) and lowest for women who had OPCAB (O/E ratio 0.46; see Table 4).
|
|
Risk-Adjusted Comparisons of Outcomes
The c-index for the propensity model was 0.905 which indicates that the model exhibits very good discrimination between those assigned to OPCAB and those assigned to CABG on CPB. Significant interactions existed between gender and surgery type when predicting death and MACE (P=0.01 for both) using the final MLR models, adjusted for the random effect of surgeon identity, STS predicted mortality risk and Body Size. Surgery type was associated with stroke (P=0.01); patients treated with CABG on CPB were more likely to experience stroke (Table 5). Female gender was significantly associated with increased incidence of postoperative MI (P=0.008). Importantly, the multiple logistic regression interaction term was significant (P=0.01) for both death and MACE, meaning that women benefited more from OPCAB than did men with respect to risk-adjusted incidence of death or MACE. However, no statistically significant interaction between gender and surgery type was present for either stroke or MI (P=0.49 and P=0.12, respectively).
|
Women treated with CABG on CPB had a risk-adjusted odds ratio of 1.60 for death (P=0.01), 1.71 for stroke (P=0.007), 2.26 for MI (P=0.008) and 1.71 for MACE (P<0.001) compared with men who had CABG on CPB. Women treated with OPCAB had outcomes statistically similar to men, with a risk-adjusted odds ratio of 0.71 for death (P=0.25), 1.36 for stroke (P=0.30), 1.08 for MI (P=0.85) and 0.96 for MACE (P=0.83) compared with men who had OPCAB. Among women, OPCAB was associated with fewer deaths (OR 2.56 CPB versus OPCAB, P=0.001), stroke (OR 2.32 CPB versus OPCAB, P=0.002) and MACE (OR 2.33 CPB versus OPCAB, P<0.001).
Indeed, treatment with OPCAB rendered women statistically similar to men in clinical outcomes: women treated with OPCAB had odds ratios of 0.63 (P=0.12) for death, 0.74 (P=0.28) for stroke, 1.69 for MI (P=0.22) and 0.73 (P=0.12) for MACE compared with men treated with CABG on CPB.
The benefit of OPCAB was less dramatic for men than for women. Among male patients, OPCAB was associated with statistically insignificant odds ratios for death, MI, and MACE compared with treatment with CABG on CPB, whereas stroke incidence (OR 1.85 CPB versus OPCAB; P=0.01) was significantly lower for OPCAB patients.
Possible Confounders of the Impact of Gender and Surgical Technique on Outcomes
Body Habitus
Some authors have proposed body habitus to be a confounder of the gender disparity in surgical outcomes after CABG. The classes of "high risk" body habitus defined by Habib et al19 and Body Size class frequencies for the present study were as follows: n=1128 very small; n=1707 slightly small; n=1622 moderately obese; n=1216 very obese; and n=5740 normal. Among the preoperative risk factors (Table 1) included directly (ie, not as part of the propensity score) in the MLR models used to derive the odds ratios presented in Table 5, were indices of unfavorable body habitus (Body Size). Body Size was included as preplanned covariate of risk in each of the final models of adverse outcomes. Body Size was not statistically significant in any of the 4 MLR models for death, stroke, MI or MACE indicating that body size does not confound the outcomes.
Completeness of Revascularization
Similarly, some authors have proposed that poorer outcomes for women after CABG are caused by less complete or effective revascularization, perhaps attributable to the small coronary arteries often found in women. To evaluate this possible explanation, the number of diseased vessels was included in the multivariable logistic regressions that generated the propensity score reported above. Moreover, an index of completeness of revascularization (ICOR) was calculated for each patient and compared between groups. ICOR was defined as the number of distal anastomoses constructed divided by the number of diseased vessels reported on the preoperative coronary arteriogram. Table 6 shows that the number of diseased vessels, the number of distal coronary artery anastomoses constructed and the ICOR were all slightly, but significantly, lower in females than in males and slightly, but significantly, lower in patients treated with OPCAB than in those treated with CABG on CPB. ICOR was lower for women treated with OPCAB than for those treated with CABG on CPB. The longer-term clinical implications of these differences are unknown. It is clear, however, that the improvement in clinical outcomes for women after OPCAB compared with conventional CABG on CPB is not attributable to more complete revascularization during OPCAB.
|
Surgeon Identity
The 11 413 CABG surgeries analyzed in this report were performed by 14 different academic surgeons over 8 years (Figure 2). One hypothetical explanation for improved surgical outcomes after OPCAB versus conventional CABG on CPB might be that the surgeon(s) performing OPCAB surgery are more skilled than those performing the older, conventional operation, rather than any inherent benefit of the technique itself. Furthermore, the distribution of cases by gender and surgery type might hypothetically affect outcome (see Table 7 and Figure 3). To address this theoretical concern, surgeon identity was included as a random effect in the final MLR models. The rationale for this approach is guided by the fact that patients are independently observed and treated except for the random effect of which surgeon is assigned to their case. The final MLRs are adjusted for the effect of surgeon identity, and thus the odds ratios for group comparisons in Table 5 reflect this adjustment.
|
|
| Discussion |
|---|
|
|
|---|
It has been long noted that women fared less well than men after cardiac surgery, and there have been numerous explanations offered,24–29 usually in the form of risk factors that might be confounders of the impact of gender on outcomes. None of these has been proven. In the present analysis the most credible explanations, namely body habitus, completeness of revascularization and surgeon identity, were tested as variables within our multivariable and propensity analyses. All were found to influence adverse cardiac events independent of gender and surgical technique. Their inclusion in these multivariable and propensity analyses did not negate the impact of gender or surgical technique on the risk-adjusted odds ratios for negative outcomes.
This study has several limitations. Its retrospective, observational nature does not permit complete accounting for all sources of bias, despite advanced statistical methodology designed to correct for both treatment selection bias and potential confounders of outcomes in preplanned analyses. In addition, the STS database used in this study reported surgical cases according to the ultimate surgery type performed until January 1, 2004, when STS introduced a data field to document intraoperative conversions from OPCAB to CABG on CPB. Because the large majority of this dataset predates the introduction of the conversion field, an intention-to-treat analysis of the entire dataset was not feasible. This meant that patients whose CABG was initially attempted without CPB and who required conversion to CPB (typically attributable to hemodynamic instability) were included in the CABG on CPB group. This may disadvantage CABG on CPB in comparison of outcomes with OPCAB. Reciprocally, patients converted from CABG on CPB to OPCAB (usually attributable to intraoperative discovery of severe aortic atherosclerosis) were included in the OPCAB group. Their increased incidence of complications may disadvantage OPCAB in comparison to CABG on CPB. Virtually all patients undergoing cardiac surgery at Emory since 1996 have had intraoperative epiaortic ultrasound scanning performed early in the procedure; thus, conversions from planned CABG on CPB to OPCAB without aortic manipulation occur on an infrequent but regular basis. Fortunately, intraoperative conversion is generally an infrequent event, affecting only
2% of cases.15 To test whether intraoperative conversion of patients from OPCAB to CABG on CPB could possibly have confounded the present analyses, all patients in the present dataset whose surgery was performed after January 1, 2004 (when the data field for conversion was introduced) were examined separately in a post hoc analysis. Among these 1611 patients, 25 (1.55%) were converted intraoperatively from a planned OPCAB to CABG on CPB. None (0) of these 25 patients experienced 30-day mortality or perioperative MI. One (4%) experienced stroke. It therefore seems unlikely that intraoperative conversion of patients from OPCAB to CABG on CPB could have meaningfully confounded the present analyses.
Finally, although the 14 surgeons who performed CABG in this study varied greatly in their interest in OPCAB (several rarely performed OPCAB, whereas several used OPCAB in the majority of their cases), Emory University has maintained a strong institutional interest in OPCAB since 1997. Thus, faculty surgeons in the present study may have average experience with OPCAB that exceeds the national norm, limiting generalizability of these results.
| Conclusion |
|---|
|
|
|---|
| Acknowledgments |
|---|
Source of Funding
This study was internally funded solely by Emory Healthcare, through the Clinical Research Unit of the Division of Cardiothoracic Surgery, without contribution from any outside corporate entity.
Disclosures
J.P., O.L., and R.G. are consultants to Medtronic, Inc. J.P. and R.G. are also consultants to Boston Scientific.
| Footnotes |
|---|
| References |
|---|
|
|
|---|
2. Koch CG, Higgins TL, Capdeville M, Maryland P, Leventhal M, Starr NJ. The risk of coronary artery surgery in women: a matched comparison using preoperative severity of illness scoring. J Cardiothorac Vasc Anesth. 1996; 10: 839–843.[CrossRef][Medline] [Order article via Infotrieve]
3. Cosgrove DM, Loop FD, Lytle BW, Baillot, MD, Gill CC, Golding LA, Taylor PC, Goormastic M. Primary myocardial revascularization: trends in surgical mortality. J Thorac Cardiovasc Surg. 1984; 88: 673–684.[Abstract]
4. Hogue CW, Barzilai B, Pieper KS, Coombs LP, DeLong ER, Kouchoukos NT, Davila-Roman VG. Sex differences in neurological outcomes and mortality after cardiac surgery: a Society of Thoracic Surgery National Database Report. Circulation. 2001; 103: 2133–2137.
5. Weintraub WS, Wenger NK, Jones EL, Craver JM, Guyton RA. Changing clinical characteristics of coronary surgery patients: differences between men and women. Circulation. 1993; 88: 79–86.
6. Edwards FH, Carey JS, Grover FL, Bero JW, Hartz RS. Impact of gender on coronary bypass operative mortality. Ann Thorac Surg. 1998: 125–131.
7. Vaccarino V, Abramson JL, Veledar E, Weintraub WS. Sex differences in hospital mortality after coronary artery bypass surgery: evidence for a higher mortality in younger women. Circulation. 2002; 105: 1176–1181.
8. Roach G, Kanchuger M, Mangano C. Adverse cerebral outcomes after coronary bypass surgery. N Engl J Med. 1996; 335: 1857–1863.
9. Newman M, Kirchner J, Phillips-Bute B. Longitudinal assessment of neurocognitive function after coronary-artery bypass surgery. N Engl J Med. 2001; 344: 395–402.
10. Edmunds L. Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg. 1998; 66: 12–16.
11. Society of Thoracic Surgeons. Spring 2005 Report. Adult Cardiac Database Executive Summary. Available at: http://www.sts.org/sections/stsnationaldatabase/publications/executive/article.html. Accessed November 25, 2005.
12. Cleveland JC, Shroyer ALW, Chen AY, Peterson E, Grover FL. Off-pump coronary artery bypass grafting decreases risk-adjusted mortality and morbidity. Ann Thorac Surg. 2001; 72: 1282–1289.
13. Plomondon ME, Cleveland JC, Ludwig ST. Off-pump coronary artery bypass is associated with improved risk-adjusted outcomes. Ann Thorac Surg. 2001; 72: 114–119.
14. Magee MM, Coombs LP, Peterson ED, Mack MJ. Patient selection and current practice strategy for off-pump coronary artery bypass surgery. Circulation. 2003; 108 (Suppl II): 9–14.
15. Puskas JD, Williams WH, Duke PG. Off-pump coronary artery bypass grafting provides complete revascularization with reduced myocardial injury, transfusion requirements, and length of stay: a prospective randomized comparison of two hundred unselected patients undergoing off-pump versus conventional coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2003; 125: 797–808.
16. Puskas J, Williams W, Mahoney E. Off-pump vs conventional coronary artery bypass grafting: early and 1-year graft patency, cost, and quality of life outcomes a randomized trial. JAMA. 2004; 291: 1841–1849.
17. Angelini G, Taylor F, Reeves B, Ascione R. Early and midterm outcome after off-pump and on-pump surgery in beating heart against cardioplegic arrest studies (BHACAS 1 and 2): a pooled analysis of two randomized controlled studies. Lancet. 2002; 359: 1194–1200.[CrossRef][Medline] [Order article via Infotrieve]
18. Van Dijk D, Nierich A, Jansen E. Early outcome after off-pump versus on-pump coronary bypass surgery. Circulation. 2001; 104: 1761–1766.
19. Habib RH, Zacharias A, Schwann TA, Riordan CJ, Durham SJ, Shah A. Effects of obesity and small body size on operative and long-term outcomes of coronary artery bypass surgery: a propensity matched analysis. Ann Thorac Surg. 2005; 79: 1976–1986.
20. Shroyer ALW, Coombs LP, Peterson ED. The Society of Thoracic Surgeons: 30-day operative mortality and morbidity risk models. Ann Thorac Surg. 2003; 75: 1856–1865.
21. Rubin DB. Inference and missing data. Biometrika. 1976; 63: 581–592.
22. DAgostino RB. Tutorial in biostatistics: propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Statistics in Medicine. 1998; 17: 2265–2281.[CrossRef][Medline] [Order article via Infotrieve]
23. Blackstone EH. Comparing apples and oranges. J Thorac and Cardiovasc Surg. 2002; 123: 8–15.
24. Aldea GS, Gaudiani JM, Shapira, OM, Jacobs, AK, Weinberg, J, Cupples, AL, Lazar, HL, Shemin, RJ. Effect of gender on postoperative outcomes and hospital stays after coronary artery bypass grafting. Ann Thorac Surg. 1999; 67: 1097–1103.
25. Koch CG, Mangano CM, Schwann N. Is it gender, methodology, or something else? J Thorac and Cardiovasc Surg. 2003; 126: 932–935.
26. Koch CG, Weng YS, Zhou SX. Prevalence of risk factors, and not gender per se, determines short- and long term survival after coronary artery bypass surgery. J Cardiothorac Vasc Anesth. 2003; 17: 585–593.[CrossRef][Medline] [Order article via Infotrieve]
27. Nussmeier NA, Marino MR, Vaughn WK. Hormone replacement therapy is associated with improved survival in women undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2002; 124: 1225–1229.
28. Wenger NK. Is whats good for the gander good for the goose? J Thorac Cardiovasc Surg. 2003; 126: 929–931.
29. Vaccarino V, Koch GC. Long-term benefits of coronary bypass surgery: are the gains for women less then for men? J Thorac Cardiovasc Surg. 2003; 126: 1707–1711.
This article has been cited by other articles:
![]() |
J. D. Puskas, V. H. Thourani, P. Kilgo, W. Cooper, T. Vassiliades, J. D. Vega, C. Morris, E. Chen, B. J. Schmotzer, R. A. Guyton, et al. Off-pump coronary artery bypass disproportionately benefits high-risk patients. Ann. Thorac. Surg., October 1, 2009; 88(4): 1142 - 1147. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. A. Cooper, V. H. Thourani, R. A. Guyton, P. Kilgo, O. M. Lattouf, E. P. Chen, C. D. Morris, J. D. Vega, T. A. Vassiliades Jr, and J. D. Puskas Racial Disparity Persists After On-Pump and Off-Pump Coronary Artery Bypass Grafting Circulation, September 15, 2009; 120(11_suppl_1): S59 - S64. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-p. Fu, Z. Zheng, X. Yuan, S.-j. Zhang, H.-w. Gao, Y. Li, and S.-s. Hu Impact of Off-Pump Techniques on Sex Differences in Early and Late Outcomes After Isolated Coronary Artery Bypass Grafts Ann. Thorac. Surg., April 1, 2009; 87(4): 1090 - 1096. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2007 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |